Premium
Cost‐effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain
Author(s) -
GutierrezRecacha P.,
Chisholm D.,
Haro J. M.,
SalvadorCarulla L.,
AyusoMateos J. L.
Publication year - 2006
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.2006.00917.x
Subject(s) - schizophrenia (object oriented programming) , psychological intervention , psychiatry , burden of disease , medicine , environmental health , psychology , gerontology , population
Objective: To estimate the cost‐effectiveness of interventions for reducing the burden of schizophrenia in Spain. Method: The study examined the cost‐effectiveness of seven different types of clinical interventions at the level of Spanish population: i) current situation; ii) older antipsychotics alone; iii) new antipsychotics alone (risperidone); iv) older antipsychotics plus psychosocial treatment; v) new antipsychotics plus psychosocial treatment; vi) older antipsychotics plus case management and psychosocial treatment; vii) new antipsychotics plus case management and psychosocial treatment. Results: Interventions based on the combination of haloperidol with psychosocial treatment or psychosocial treatment plus case management proved to be the most efficient strategies. Conclusion: The relatively modest additional cost of concurrent psychosocial treatment has significant health gains, thereby making such a combined strategy for schizophrenia more cost‐effective than pharmacology alone.